The abstract is read at the publisher; the summary is JClub's.
SARS-CoV-2 mRNA vaccination during or within 30 days before pregnancy is linked to equivalent ASQ-3 total scores at 18–30 months (255 vs 260; adjusted median difference -3.4).
- Why it matters: Long-term neurodevelopmental effects of in utero exposure to SARS-CoV-2 mRNA vaccination are not well established, limiting evidence needed for pregnancy vaccine guidance.
- What they did: In a multicenter prospective cohort (14 Maternal-Fetal Medicine Units Network centers, 2024–2025), 217 matched exposed–unexposed pairs were compared using ASQ-3 total score equivalence based on a 90% CI between -10 and 10.
- The result: ASQ-3 total scores met equivalence (90% CI -9.8 to 3.0), and secondary neurodevelopment measures showed no significant differences, supporting continued pregnancy vaccination recommendations.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.